ADMA Biologics, Inc. drugs
2 results
Asceniv (human immunoglobulin g)
(HUMAN IMMUNOGLOBULIN G)ADMA Biologics, Inc.
Usage: ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents aged 12 to 17. This includes conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Bivigam (immune globulin intravenous (human) 10%)
(Immune Globulin Intravenous (Human) 10%)ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency in adults and children aged 2 years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.